IL6R and sarcoidosis: While few cases showed the efficacy of anti-interleukin-6 (IL-6) or IL-6 receptor (IL-6R) agents in refractory sarcoidosis [3], new-onset sarcoidosis during TCZ treatment has been described in five case reports [137,138,139,140,141].